Moreover, elevated expression of SREBP1 is closely correlated with malignant transformation, cancer progression, and metastasis for several cancer types, particularly hormone-responsive tissue-derived cancers, such as breast and prostate cancers [9,11,13,14], whereas suppression of SREBP1 may inhibit tumor growth [15]. The gene discussed is SREBF1; the disease is prostate carcinoma.